Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants von Randolph, SophiaS.B., Gooley, Theodore A., Warren, Edus H., Appelbaum, Frederick R., Riddell, Stanley R.

Volltext

Early phase II trial of oral vorinostat in relapsed or refractory breast, colorectal, or non-small cell lung cancer von Vansteenkiste, Johan, Van Cutsem, Eric, Dumez, Herlinde, Chen, Cong, Ricker, Justin L., Randolph, Sophia S., Schöffski, Patrick

Volltext

Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-es... von Lakhani, Nehal J, Chow, Laura Q M, Gainor, Justin F, LoRusso, Patricia, Lee, Keun-Wook, Chung, Hyun Cheol, Lee, Jeeyun, Bang, Yung-Jue, Hodi, Frank Stephen, Kim, Won Seog, Santana-Davila, Rafael, Fanning, Philip, Squifflet, Pierre, Jin, Feng, Kuo, Tracy C, Wan, Hong I, Pons, Jaume, Randolph, Sophia S, Messersmith, Wells A

Volltext

Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer von FLAHERTY, Keith T, LORUSSO, Patricia M, DEMICHELE, Angela, ABRAMSON, Vandana G, COURTNEY, Rachel, RANDOLPH, Sophia S, SHAIK, M. Naveed, WILNER, Keith D, O'DWYER, Peter J, SCHWARTZ, Gary K

Volltext

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes von Garcia-Manero, Guillermo, Yang, Hui, Bueso-Ramos, Carlos, Ferrajoli, Alessandra, Cortes, Jorge, Wierda, William G., Faderl, Stefan, Koller, Charles, Morris, Gail, Rosner, Gary, Loboda, Andrey, Fantin, Valeria R., Randolph, Sophia S., Hardwick, James S., Reilly, John F., Chen, Cong, Ricker, Justin L., Secrist, J. Paul, Richon, Victoria M., Frankel, Stanley R., Kantarjian, Hagop M.

Volltext

ALX148, a CD47 Blocker, in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma von Kim, Tae Min, Lakhani, Nehal, Gainor, Justin, Kamdar, Manali, Fanning, Philip, Squifflet, Pierre, Jin, Feng, Forgie, Alison J., Wan, Hong, Pons, Jaume, Randolph, Sophia S, Kim, Won Seog

Volltext

ALX148 Enhances the Depth and Durability of Response to Multiple AML Therapies von Chen, Amy, Harrabi, Ons, Fong, Abraham P, Ruffner, Katherine L., Forgie, Alison J., Sim, Janet, Randolph, Sophia S, Wan, Hong, Pons, Jaume, Kuo, Tracy C

Volltext

Evorpacept (ALX148), a CD47-Blocking Myeloid Checkpoint Inhibitor, in Combination with Azacitidine: A Phase 1 / 2 Study in Patients with Myelodysplastic Syndrome (ASPEN-02) von Garcia-Manero, Guillermo, Erba, Harry P., Sanikommu, Srinivasa R., Altman, Jessica K., Sayar, Hamid, Scott, Bart L., Fong, Abraham P., Guan, Shanhong, Jin, Feng, Forgie, Alison J., Pons, Jaume, Randolph, Sophia S., Byrne, Michael T.

Volltext

A Phase 1 Study of ALX148, a CD47 Blocker, in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma von Kim, Tae Min, Lakhani, Nehal, Gainor, Justin, Kamdar, Manali, Fanning, Philip, Squifflet, Pierre, Jin, Feng, Wan, Hong, Pons, Jaume, Randolph, Sophia S, Kim, Won Seog

Volltext

Abstract CT101: Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for firs... von Finn, Richard S., Crown, John P., Lang, Istvan, Boer, Katalin, Bondarenko, Igor M., Kulyk, Sergey O., Ettl, Johannes, Patel, Ravindranath, Pinter, Tamas, Schmidt, Marcus, Shparyk, Yaroslav V., Thummala, Anu R., Voytko, Nataliya L., Huang, Xin, Kim, Sindy T., Randolph, Sophia S., Slamon, Dennis J.

Volltext

Palbociclib and Letrozole in Advanced Breast Cancer von Finn, Richard S, Martin, Miguel, Rugo, Hope S, Jones, Stephen, Im, Seock-Ah, Gelmon, Karen, Harbeck, Nadia, Lipatov, Oleg N, Walshe, Janice M, Moulder, Stacy, Gauthier, Eric, Lu, Dongrui R, Randolph, Sophia, Diéras, Véronique, Slamon, Dennis J

Volltext

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer von Turner, Nicholas C, Ro, Jungsil, André, Fabrice, Loi, Sherene, Verma, Sunil, Iwata, Hiroji, Harbeck, Nadia, Loibl, Sibylle, Huang Bartlett, Cynthia, Zhang, Ke, Giorgetti, Carla, Randolph, Sophia, Koehler, Maria, Cristofanilli, Massimo

Volltext

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, ad... von Finn, Richard S, MD, Crown, John P, Prof, Lang, Istvan, MD, Boer, Katalin, MD, Bondarenko, Igor M, Prof, Kulyk, Sergey O, MD, Ettl, Johannes, MD, Patel, Ravindranath, MD, Pinter, Tamas, MD, Schmidt, Marcus, MD, Shparyk, Yaroslav, MD, Thummala, Anu R, MD, Voytko, Nataliya L, MD, Fowst, Camilla, MD, Huang, Xin, PhD, Kim, Sindy T, BS, Randolph, Sophia, MD, Slamon, Dennis J, Prof

Volltext

Prevalence of Disorder Eating Symptoms in Black and/or Hispanic Identifying Young Adults von Leissa, Sophia, Randolph, Jillian, Stephens, Janna

Volltext

Prediction of Motor Recovery Using Initial Impairment and fMRI 48 h Poststroke von Zarahn, Eric, Alon, Leeor, Ryan, Sophia L., Lazar, Ronald M., Vry, Magnus-Sebastian, Weiller, Cornelius, Marshall, Randolph S., Krakauer, John W.

Volltext

Recruitment of Black Identifying Young Adults into Clinical Trials: a Report from the Field von Leissa, Sophia M., Randolph, Jillian C., Stephens, Janna D.

Volltext

Recruitment of Black Identifying Young Adults into Wellness Clinical Trials von Leissa, Sophia, Randolph, Jillian, Thein, Erica, Stephens, Janna

Volltext

Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer von KONECNY, Gottfried E, WINTERHOFF, Boris, KALLI, Kimberly R, FINN, Richard S, GINTHER, Charles, JONES, Siân, VELCULESCU, Victor E, RIEHLE, Darren, CLIBY, William A, RANDOLPH, Sophia, KOEHLER, Maria, HARTMANN, Lynn C, KOLAROVA, Teodora, SLAMON, Dennis J, JINGWEI QI, MANIVONG, Kanthinh, DERING, Judy, GUORONG YANG, CHALUKYA, Meenal, WANG, He-Jing, ANDERSON, Lee

Volltext

Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from... von Finn, Richard S, Crown, John P, Ettl, Johannes, Schmidt, Marcus, Bondarenko, Igor M, Lang, Istvan, Pinter, Tamas, Boer, Katalin, Patel, Ravindranath, Randolph, Sophia, Kim, Sindy T, Huang, Xin, Schnell, Patrick, Nadanaciva, Sashi, Bartlett, Cynthia Huang, Slamon, Dennis J

Volltext

Abstract P183: Elevated Phq-9 Scores In Black And Hispanic Young Adults von Stephens, Janna D, Randolph, Jillian, Leissa, Sophia, Miller, Carla, Melnyk, Bernadette, Burke, Lora E, Buffington, Brenda, Tan, Alai

Volltext